SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003366
Filing Date
2021-03-23
Accepted
2021-03-23 13:42:47
Documents
17
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20201231x10k.htm 10-K 1599160
2 EX-4.2 tmb-20201231xex4d2.htm EX-4.2 22916
3 EX-23.1 tmb-20201231xex23d1.htm EX-23.1 3401
4 EX-31.1 tmb-20201231xex31d1.htm EX-31.1 14785
5 EX-31.2 tmb-20201231xex31d2.htm EX-31.2 14524
6 EX-32 tmb-20201231xex32.htm EX-32 17740
7 GRAPHIC tmb-20201231x10k011.jpg GRAPHIC 52018
8 GRAPHIC tmb-20201231x10k005.jpg GRAPHIC 13040
9 GRAPHIC tmb-20201231x10k003.jpg GRAPHIC 18316
10 GRAPHIC tmb-20201231x10k010.jpg GRAPHIC 42673
11 GRAPHIC tmb-20201231x10k012.jpg GRAPHIC 20138
12 GRAPHIC tmb-20201231x10k001.jpg GRAPHIC 34728
13 GRAPHIC tmb-20201231x10k007.jpg GRAPHIC 27875
14 GRAPHIC tmb-20201231x10k002.jpg GRAPHIC 32518
15 GRAPHIC tmb-20201231x10k009.jpg GRAPHIC 38766
16 GRAPHIC tmb-20201231x10k004.jpg GRAPHIC 31087
17 GRAPHIC tmb-20201231x10k006.jpg GRAPHIC 11326
  Complete submission text file 0001558370-21-003366.txt   2119425
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39811 | Film No.: 21764076
SIC: 2834 Pharmaceutical Preparations